Valuation (33%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 31.70 | N/A |
| PEG Ratio (TTM) | 3.09 | N/A |
| P/S Ratio (TTM) | 3.48 | N/A |
| P/B Ratio (TTM) | 19.75 | N/A |
| P/FCF Ratio (TTM) | 10.67 | N/A |
| Price to 5YR AVG Earnings Ratio | N/A | N/A |
| Price to 5YR AVG FCF Ratio | N/A | N/A |
Profitability (55%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 9.36% | N/A |
| ROE (TTM) | 47.16% | N/A |
| Net Profit Margin (TTM) | 10.93% | N/A |
| ROIC 5YR AVG | N/A | N/A |
Growth (50%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 11.93% | -720.80% | N/A |
| Revenue | 5.47% | 34.10% | N/A |
| Net Income | 12.79% | -351.70% | N/A |
| Cash Flow | 483.38% | 210.66% | N/A |
Health (32%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 1.07 | N/A |
| Quick Ratio (TTM) | 1.07 | N/A |
| D/E Ratio (TTM) | N/A | N/A |
| Interest Coverage (TTM) | 13.88 | N/A |
| Piotroski F-Score | 6 | N/A |
| Altman Z-Score | 3.49 | N/A |
| LTL to 5YR AVG FCF | N/A | N/A |
| Shares Outstanding Growth 5YR AVG | N/A | N/A |